Clinical and pathological characteristics of steatohepatitis in patients with chronic hepatitis C virus infection

World Chinese Journal of Digestology

Volumn 10, Issue 9, 2002, Pages 1009-1013

  Li, Li ^a   Cheng, Jun ^a   Li, Fan ^a   Wang, Jian Jun ^a   Zhang, Jian ^a   Wu, Qin ^a   Han, Ping ^a   Chen, Guo Feng ^a   Ji, Dong ^a   Li, Ke ^a  

^a BEIJING 302 HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD TRANSFUSION; CHRONIC DISEASE; DISEASE SEVERITY; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SEX DIFFERENCE; STATISTICAL ANALYSIS; STEATOSIS; VIRUS INFECTION;

EID: 0036737873     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Cheng J, Zhong YW, Liu Y, Dong J, Yang JZ, Zhang LX. Screening and identification of a humanized single chain variable region antibody for hepatitis C virus non-structural 3 protein. Chin J Immunol 2000;16:246-249
2. Castera L, Hezode C, Roudot-Thoraval F, Bastie A, Zafrani ES, Pawlotsky JM. Steatosis evolution is a main determinant of fibrosis progression in untreated patients with chronic hepatitis C. J Hepatol 2002; 36(Suppl 1):102-103
3. Jarmay K, Karacsony G, Nagy I, Lonovics J, Schaff Z. Changes in lipid metablism in chronic hepatitis C. J Hepatol 2002; 36(Supp1 1):113
4. Hezode C, Roudot-Thoraval F, Bralet MP, Mallat A, Pawlotsky JM, Zafrani ES. Factors associated with steatosis and the severety of the disease in patients with chronic hepatitis C. J Hepatol 2002; 36(Suppl 1)::111
5. Thomssen R, Bonk S, Propfe C. Association of hepatitis C virus in human sera with beta-lipoprotein. Med Microbiol Immunol (Berl) 1992;181:293-300
6. Thomssen R, Bonk S, Thiele A.Density heterogeneities of hepatitis C virus in human sera due to the binding of betalipoproteins and immunogobulins. Med Microbiol Immunol (Berl) 1993;182:329-334
7. Goodman ZD, Ishak KG. Histopathology of hepatitis C virus infection. Semin Liver Dis 1995; 15:70-81
8. Cheng J. Molecular pathogenesis of viral hepatitis. J Gastroenterol Hepatol 2002;16(Suppl):A185
9. Lerat H, Honda M, Tseng CTK, Gosert R, Ping LH, Lemon SM. Hepatitis C virus transgenic mice as model for HCV associated liver disease (Abstract). Hepatology 1998;(Suppl) 28:498A
10. Monazahian M, Kippenberger S, Muller A, Seitz H, Bohme I, Grethe S, Thomssen R. Binding of human lipoproteins (low, very low, high density lipoprotein) to recombinant envelope proteins of hepatitis C virus. Med Microbiol Immnol (berl) 2000; 188: 177-184
11. Sabile A, Perlemuter G, Bono F, Koham K, Demaugre F, Kohara M, Matsuura Y, Miyamura T, Brechot C, Barba G. Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology 1999;30:1064-1076
12. Hope RG, Mclauchlau J. Sequence motifs required for lipid droplet associationand protein stability are unique to the hepatitis C virus core protein. J Gen Virol 2000;81:1913-1925
13. Marson P, Boschetto R, De Silvestro G, Martini S, Gabelli C, Buoro S, Giordano R.Changs in HCV viremia following LDL apheresis in a HCV positive patient with familial hypercholesterolemia. Palu G Int J Artif Organs 1999; 22: 640-644